DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Explore the future of healthcare with carefully selected information.
Login
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open
innovation from Tokyo, where you can experience the intersection of cool and passionate design and
technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Juntendo University and Rhelixa Acquire Patent for Mild Cognitive Impairment Detection Method Using DNA Methylation Prediction Model
Juntendo University and Rhelixa have acquired a patent for a method to detect Mild Cognitive Impairment (MCI) using a DNA methylation prediction model. MCI is a precursor to dementia, and its early detection is crucial for delaying progression. This technology calculates a dementia risk score based on the methylation rates at specific CpG sites in genomic DNA obtained from biological samples such as blood. A unique predictive model, developed through the analysis of blood samples from dementia patients with varying severities and healthy individuals, enables highly accurate and straightforward detection of MCI. This innovation is expected to lead to the development of early diagnostic kits and medical support systems.
World's First: Raymay to Begin Clinical Trials for iPS Cell-Derived Corneal Epithelial Cell Sheet
iPS Portal Corporation and Raymay Co., Ltd. have announced the start of corporate clinical trials for "REM-01," the world's first allogeneic iPS cell-derived corneal epithelial cell sheet. Based on iPS cell technology developed by Osaka University, REM-01 offers advantages in terms of supply and quality compared to existing products. The companies aim to complete clinical trials and apply for full approval by 2027. iPS Portal plans to promote a society where autologous iPS cells are utilized through its BRR business, marking a significant step towards realizing ultimate personalized medicine.
2nd Nature Launches First AI-Discovered Portfolio of Functional Ingredients
2nd Nature, developer of the AgWaste Portal AI platform, has launched its first portfolio of AI-discovered functional ingredients, including non-calorie natural sweeteners and non-sodium umami enhancers. These ingredients, found in the side streams of widely processed crops like wheat, soy, rice, peanut, and corn, are designed to help manufacturers reformulate food and beverage products to reduce sugar and sodium while maintaining taste and functionality. The company has filed a patent for these newly identified compounds, which are expected to be available for commercial sampling in Q2 2026.
Announcement of Next-Generation Amino Acid "BEAA(R)" - Addressing Soaring Prices and Procurement Risks of Whey Protein
Toyo Shinyaku Co., Ltd. has developed and launched ODM/OEM services for "BEAA (Balanced Essential Amino Acid)," a next-generation amino acid that supports body building from exercise, equivalent to 20g of whey protein with just 3g. Developed over approximately three years to address insufficient protein intake and the rising costs and procurement risks of whey protein, BEAA combines BCAA and EAA in a unique balance. It efficiently supports body building with a small intake, enabling product development suitable for a wide range of users from athletes to the elderly, and serves as an effective alternative to whey protein.
Breath-Based Testing Emerges as Tool for Monitoring Microbiome Health
Researchers at Washington University School of Medicine and Children’s Hospital of Philadelphia have developed a rapid, noninvasive breath-based test to monitor gut microbiome health. The study showed that volatile organic compounds (VOCs) in exhaled breath can reveal the composition of gut bacteria, including those linked to conditions like asthma. This innovative approach could lead to early detection and prompt interventions for various gut health issues, offering a significant advancement in clinical care, especially for children.
Self-determined living in old age through smart home technology
Smart assistance for senior citizens: The University of Siegen is part of the GAiST project, which is researching how the use of medical vital data measuring devices in combination with state-of-the-art sensor technology can help older people to live independently and age-appropriately in their own homes for a long time.
Stretchable and self-adhesive triboelectric sensor for real-time musculoskeletal monitoring and personalized recovery
This study introduces a flexible, self-powered triboelectric nanogenerator (MB-TENG) made from medical elastic bandages for biomechanical sensing during rehabilitation and gait analysis. The MB-TENG shows robust electrical performance and long-term stability, achieving high voltage, current, and charge. Its self-adhesive nature allows for multi-layer assembly, and stretching enhances output. A stacked design improves power capacity for wearable medical electronics. The device accurately detects motion and abnormal gait, highlighting its potential as a low-cost, scalable platform for personalized rehabilitation, injury monitoring, and early musculoskeletal diagnosis.
StudyRadar.ai Expands AI-Powered Healthcare Learning Platform Across North America
StudyRadar.ai has expanded its AI-powered healthcare learning platform across Canada and the United States. Targeting pharmacy students, pharmacy technicians, medical students, and nursing professionals, the platform integrates an AI-powered OSCE simulator, advanced learning tools, and institutional solutions for the $14.6 billion healthcare e-learning market. StudyRadar addresses critical healthcare education barriers by providing personalized, clinically realistic learning for PEBC, NAPLEX, MCCQE, and NCLEX exam preparations, featuring scalable OSCE simulation, real-time clinical feedback, intelligent Anki flashcards, and adaptive MCQ generators. Alberta-based StudyRadar.ai is building North America's most comprehensive healthcare learning ecosystem, powered by responsible AI innovation.
Toward a “5-fold expansion” of the treatable window: Japan-developed candidate drug for cerebral infarction
Currently, TMS-007, developed by Timus, not only dissolves blood clots but also suppresses inflammation in the brain. This is expected to enable the treatment of cerebral infarction by dissolving clots while reducing the risk of cerebral hemorrhage. A clinical trial (early Phase II clinical trial) conducted by our company in Japan in 2018 suggested that TMS-007 suppresses cerebral hemorrhage occurring after cerebral infarction, potentially enabling safer treatment compared to existing drugs.
IHI Succeeds in Synthesizing Sustainable Aviation Fuel (SAF) from CO₂ using a Test Facility, Verifying Excellent Properties Meeting International Standards at a Specialized Institution
IHI announced its success in synthesizing sustainable aviation fuel (SAF) from CO₂ and hydrogen at a test facility scale. The synthesized SAF was evaluated by Washington State University in the U.S. and confirmed to have favorable properties as an alternative jet fuel for aircraft. This represents a significant step towards the commercialization of SAF via direct synthesis, and IHI aims for early establishment of efficient and stable SAF manufacturing technology to contribute to the goal of net-zero CO₂ emissions from aircraft by 2050.
A Study on the Discovery of Gut Bacteria Characteristic of Underweight Young Japanese Women
Professor Katsumi Iizuka of the Department of Clinical Nutrition, School of Medicine, Fujita Health University (Toyoake City, Aichi Prefecture) and Symbiosis Solutions Inc. (Headquarters: Chiyoda Ward, Tokyo) conducted a joint study comparing dietary diversity and gut microbial diversity in women aged 20-39 years (80 participants total), divided into underweight and normal weight groups. Regarding dietary surveys, no significant differences were observed between the underweight and normal-weight groups in terms of energy intake, nutrients, or dietary diversity. However, the underweight group exhibited lower gut microbiota diversity and a higher abundance of bacteria associated with inflammation compared to the normal-weight group. Dietary therapy targeting the gut microbiota may alter the intestinal environment and potentially improve underweight conditions.
New nanotechnology drug reduces amyloid beta in mouse brains by 50 to 60 percent
While scientists still do not know what exactly causes Alzheimer’s disease, previous research shows there are a number of potential factors.
A new study explains how a research team was able to use a new nanotechnology strategy to reverse Alzheimer’s disease in mice with the condition.
The new nanotechnology helped reduce amyloid-beta in the mice’s brains by 50-60%.
Ainos secures seven new patents for AI-powered scent technology
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW), whose stock has surged over 40% in the past six months according to InvestingPro data, has secured seven new patents in Europe, Germany, Taiwan, and China for its AI Nose digital olfaction platform, the company announced Tuesday.
The new patents bring Ainos’s total to 123 active patents across the U.S., Europe, Germany, Japan, Taiwan, and China, covering product design, internal structures, system configurations, and operating principles of its scent digitization technology. With a market capitalization of $16.6 million, the company trades at 1.45 times book value.
The AI Nose platform is designed to convert scent into digital data using MEMS sensor arrays and AI algorithms, with applications across multiple industries. The technology aims to provide real-time scent detection for healthcare settings, anomaly detection in semiconductor manufacturing, and sensory capabilities for robotics and automated production lines.